NEW YORK, Aug. 31, 2017 /PRNewswire/ -- Juan
Monteverde, founder and managing partner at Monteverde &
Associates PC, a boutique securities firm headquartered at the
Empire State Building in New York
City, is investigating Kite Pharma, Inc. ("Kite Pharma" or
the "Company") (NASDAQ: KITE) relating to the sale of the Company
to affiliates of Gilead Sciences, Inc. (NASDAQ: GILD). As a result
of the merger, Kite Pharma shareholders are only anticipated to
receive $180.00 in cash in exchange
for each share of Kite Pharma.
Click here for more information:
http://monteverdelaw.com/investigations/m-a/. It is free
and there is no cost or obligation to you.
The investigation focuses on whether Kite Pharma and its Board
of Directors violated securities laws and/or breached their
fiduciary duties to the Company's by 1) failing to conduct a fair
process and 2) whether and by how much this proposed transaction
undervalues the Company.
Monteverde & Associates PC is a boutique class action
securities and consumer litigation law firm that has recovered
millions of dollars and is committed to protecting
shareholders and consumers from corporate wrongdoing.
Monteverde & Associates lawyers have significant experience
litigating Mergers & Acquisitions and Securities Class Actions,
whereby they protect investors by recovering money and remedying
corporate misconduct.
If you own common stock in Kite Pharma and wish to obtain
additional information and protect your investments free of charge,
please visit our website or contact Juan E.
Monteverde, Esq. either via e-mail at
jmonteverde@monteverdelaw.com or by telephone at (212)
971-1341.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2017 Monteverde & Associates
PC. The law firm responsible for this advertisement is
Monteverde & Associates PC (www.monteverdelaw.com). Prior
results do not guarantee a similar outcome with respect to any
future matter.
View original content with
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde--associates-pc-announces-an-investigation-of-kite-pharma-inc--kite-300512683.html
SOURCE Monteverde & Associates PC
